Finance

Lists
AURA:NASDAQ
Aura Biosciences Inc
USD 6,61
+1,61%
(+0,11) 1D
9 Okt., 14:15:53 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
USD 6,48
High
USD 6,70
Low
USD 6,46
Mkt. cap
684,96 m
Avg. vol.
887,25 k
Volume
360,38 k
52-wk high
USD 9,54
52-wk low
USD 4,73
EPS
-USD 1,76
Beta
0,41
Shares outstanding
103,70 m
No. of employees
113
Open
USD 6,48
High
USD 6,70
Low
USD 6,46
Mkt. cap
684,96 m
Avg. vol.
887,25 k
Volume
360,38 k
52-wk high
USD 9,54
52-wk low
USD 4,73
EPS
-USD 1,76
Beta
0,41
Shares outstanding
103,70 m
No. of employees
113
News stories
From web sources and news partners
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersBoston, Massachusetts, Verenigde State van Amerika
Sector-
Websiteaurabiosciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to AURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current USD 6,61
USD 23,00 (+247,96%)
Average
USD 20,50 (+210,14%)
Lowest
USD 18,00 (+172,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver McCammon
LifeSci Capital
Buy
Maintained
USD 23,00
+248%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
USD 18,00
+172,3%
08/12/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
USD 15,00
+126,9%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,18 m
21,90 m
27,96 m
30,75 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,73 m
5,34 m
6,91 m
17,32 m
Operating expense
27,91 m
27,24 m
34,87 m
48,07 m
Total operating expenses
27,91 m
27,24 m
34,87 m
48,07 m
Operating income
-27,91 m
-27,24 m
-34,87 m
-48,07 m
Other non operating income
-13,00 k
149,00 k
2,00 k
154,00 k
EBT including unusual items
-26,10 m
-25,54 m
-33,67 m
-45,61 m
EBT excluding unusual items
-26,10 m
-25,54 m
-33,67 m
-45,61 m
Income tax expense
26,00 k
15,00 k
11,00 k
29,00 k
Effective tax rate
-0,10%
-0,06%
-0,03%
-0,06%
Other operating expenses
-
-
-
-
Net income
-26,13 m
-25,56 m
-33,68 m
-45,64 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,82 m
1,54 m
1,19 m
2,31 m
Interest expense
-
-
-
-
Net interest expenses
1,82 m
1,54 m
1,19 m
2,31 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,63 m
-26,96 m
-34,59 m
-47,81 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme